News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
PROEHL GERALD T
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/18/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
01/05/2022 |
4
| PROEHL GERALD T (President, CEO and Chairman) has filed a Form 4 on Dermata Therapeutics, Inc.
Txns:
| Granted 197,610 options to buy
@ $1.88, valued at
$371.5k
Granted 4,517 options to buy
@ $2.068, valued at
$9.3k
Granted 42,141 options to buy
@ $2.068, valued at
$87.1k
Granted 57,859 options to buy
@ $1.88, valued at
$108.8k
|
|
11/26/2021 |
4
| PROEHL GERALD T (President, CEO and Chairman) has filed a Form 4 on Dermata Therapeutics, Inc.
Txns:
| Bought 20,000 shares
@ $2.4, valued at
$48k
|
|
08/27/2021 |
SC 13D
| PROEHL GERALD T reports a 39.2% stake in Dermata Therapeutics, Inc. |
08/17/2021 |
4
| PROEHL GERALD T (President, CEO and Chairman) has filed a Form 4 on Dermata Therapeutics, Inc.
Txns:
| Bought 10,000 shares
@ $4.9631, valued at
$49.6k
Converted 17,857 shares
@ $0 Converted 8,928 shares
@ $0 Converted 35,767 shares
@ $0 Converted 361,147 shares
@ $0 Converted 111,951 shares
@ $0 Converted 181,585 shares
@ $0 Converted 1,247,904 shares
@ $0 Converted 85,640 shares
@ $0 Bought 142,857 shares
@ $0 Converted 120,481 options to buy
@ $0 |
|
08/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/15/2020 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on TENAX THERAPEUTICS, INC.
Txns:
| Granted 500 options to buy
@ $0.66, valued at
$330 |
|
06/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/18/2019 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on TENAX THERAPEUTICS, INC.
Txns:
| Granted 500 options to buy
@ $6.23, valued at
$3.1k
|
|
06/28/2018 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 20,000 options to buy
@ $2.91, valued at
$58.2k
|
|
01/25/2018 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on RITTER PHARMACEUTICALS INC
Txns:
| Granted 30,000 options to buy
@ $0.34, valued at
$10.2k
|
|
06/01/2017 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 20,000 options to buy
@ $2.44, valued at
$48.8k
|
|
11/30/2016 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on RITTER PHARMACEUTICALS INC |
11/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/29/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
05/31/2016 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 8,250 options to buy
@ $0.99, valued at
$8.2k
|
|
10/15/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/25/2015 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on RITTER PHARMACEUTICALS INC |
05/28/2015 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 8,250 options to buy
@ $1.08, valued at
$8.9k
|
|
05/06/2015 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Unknown transaction of 1,466 shares
@ $0 Disposed/sold 13,333 options to buy
@ $6.57, valued at
$87.6k
Disposed/sold 6,667 options to buy
@ $18.13, valued at
$120.9k
|
|
09/22/2014 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Bought 1,466 shares
@ $21.7499, valued at
$31.9k
|
|
09/19/2014 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Bought 10,000 shares
@ $3.1599, valued at
$31.6k
|
|
06/18/2014 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 1,627 options to buy
@ $2.35, valued at
$3.8k
|
|
05/07/2014 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Granted 6,667 options to buy
@ $18.13, valued at
$120.9k
|
|
03/24/2014 |
4
| PROEHL GERALD T (Director) has filed a Form 4 on SOPHIRIS BIO INC.
Txns:
| Granted 16,500 options to buy
@ $3.53, valued at
$58.2k
|
|
01/06/2014 |
4
| PROEHL GERALD T (President & CEO) has filed a Form 4 on SANTARUS INC
Txns:
| Granted 60,111 shares
@ $7.15, valued at
$429.8k
Granted 14,506 shares
@ $6.79, valued at
$98.5k
Granted 24,455 shares
@ $6.9, valued at
$168.7k
Granted 16,257 shares
@ $2.36, valued at
$38.4k
Granted 70,997 shares
@ $1.18, valued at
$83.8k
Granted 18,665 shares
@ $4.63, valued at
$86.4k
Granted 16,408 shares
@ $3.33, valued at
$54.6k
Granted 11,942 shares
@ $3.33, valued at
$39.8k
Disposed/sold 233,341 shares
@ $32, valued at
$7.5M
Unknown transaction of 30,538 shares
@ $32, valued at
$977.2k
Paid exercise price by delivering 31,249 shares
@ $32, valued at
$1000k
|
|
12/17/2013 |
4
| PROEHL GERALD T (President & CEO) has filed a Form 4 on SANTARUS INC
Txns:
| Gifted 56,643 shares
@ $0 Gifted 56,643 shares
@ $0 Sold 56,643 shares
@ $31.945, valued at
$1.8M
Exercised 56,643 options to buy
@ $3.5, valued at
$198.3k
|
|
11/19/2013 |
4
| PROEHL GERALD T (President & CEO) has filed a Form 4 on SANTARUS INC
Txns:
| Gifted 56,644 shares
@ $0 Gifted 56,644 shares
@ $0 Sold 56,644 shares
@ $32.0194, valued at
$1.8M
Exercised 56,644 options to buy
@ $3.5, valued at
$198.3k
|
|
10/16/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/07/2013 |
4
| PROEHL GERALD T (President & CEO) has filed a Form 4 on SANTARUS INC
Txns:
| Sold 86,603 shares
@ $18.7345, valued at
$1.6M
Exercised 86,603 options to buy
@ $0.875, valued at
$75.8k
|
|
03/12/2013 |
4
| PROEHL GERALD T (President & CEO) has filed a Form 4 on SANTARUS INC
Txns:
| Granted 450,000 options to buy
@ $15.42, valued at
$6.9M
|
|
|
|
|